Ekso Bionics Holdings, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Segment Disclosures (Tables)

Segment Disclosures (Tables)

12 Months Ended

Dec. 31, 2013

Schedule of Segment Reporting Information

Segment reporting information is as follows:

	Engineering		Medical
	Services		Devices		Total

Year ended December 31, 2013
Revenue	$	1,690,235	$	1,611,709	$	3,301,944
Cost of revenue		1,253,942		1,460,692		2,714,634
Gross profit	$	436,293	$	151,017	$	587,310

Year ended December 31, 2012
Revenue	$	2,140,355	$	566,222	$	2,706,577
Cost of revenue		1,782,848		553,429		2,336,277
Gross profit	$	357,507	$	12,793	$	370,300

Schedule of Geographic Information

Geographic information based on location of customer is as follows:

	For the years ended December 31,
	2013		2012

United States	$	2,810,973	$	2,652,265
Europe		418,876		54,312
Other		72,095		-
	$	3,301,944	$	2,706,577

Schedule of Revenue by Major Customer

Major customers based on revenue are as follows:

	For the years ended December 31,
	2013		2012
Lockheed Martin (Astrolink)	$	337,796	$	568,002
National Science Foundation		780,579		874,492
U.S. Federal Government		150,000		416,422
Defense Advanced Research Projects Agency		411,360	$	281,440

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details